Celebrating the great minds that bring us innovation in small molecules, biopharmaceuticals, and advanced medicine.
The Medicine Maker speaks with Christophe Le Ret, Global Marketing Director of Umicore
The Medicine Maker speaks with Angela Strzelecki, Global Business Director of Dupont
A good CDMO is a true partner with advice on getting the most from your molecule.
CPhI Worldwide will return on October 9-11, 2018, at the IFEMA, Feria de Madrid, Spain.
Interest in cannabinoid drug development is growing. The potential market – and the opportunity to treat unmet patient needs – is enormous.
Beatriz Domínguez and Ahir Pushpanath
Enzyme engineering has opened up new possibilities in biocatalysis, but computational techniques and smart libraries also make wildtypes feasible. The choice is yours.
Why we shouldn’t forget gelatin’s longstanding reputation as a reliable and trusted excipient.
Here, James speaks with Christophe Le Ret from Umicore.
Products are becoming increasingly complex and we need to get better at recognizing the strategies with the best advantages.
Antibody drug conjugates have not yet lived up to their potential, but there is hope – if we turn to the right solutions and techniques.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.